Alain De Pover

3.3k total citations · 1 hit paper
25 papers, 1.6k citations indexed

About

Alain De Pover is a scholar working on Molecular Biology, Oncology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, Alain De Pover has authored 25 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Molecular Biology, 8 papers in Oncology and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in Alain De Pover's work include Ion channel regulation and function (5 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Ion Transport and Channel Regulation (4 papers). Alain De Pover is often cited by papers focused on Ion channel regulation and function (5 papers), Cardiac electrophysiology and arrhythmias (5 papers) and Ion Transport and Channel Regulation (4 papers). Alain De Pover collaborates with scholars based in Switzerland, Belgium and United States. Alain De Pover's co-authors include Patrick Chêne, Théophile Godfraind, Pascal Furet, Christian Schnell, Christine Fritsch, Sauveur-Michel Maira, Saskia M. Brachmann, Josef Brueggen, Marjo Simonen and William R. Sellers and has published in prestigious journals such as Nature, Blood and Cancer Research.

In The Last Decade

Alain De Pover

24 papers receiving 1.5k citations

Hit Papers

Identification and characterization of NVP-BEZ235, a new ... 2008 2026 2014 2020 2008 250 500 750

Peers

Alain De Pover
Clint Mitchell United States
Babita Madan Singapore
Ramzi M. Mohammad United States
Janeen H. Trembley United States
Kendra D. Tutsch United States
Kyung Song United States
Lijun Di China
Clint Mitchell United States
Alain De Pover
Citations per year, relative to Alain De Pover Alain De Pover (= 1×) peers Clint Mitchell

Countries citing papers authored by Alain De Pover

Since Specialization
Citations

This map shows the geographic impact of Alain De Pover's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alain De Pover with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alain De Pover more than expected).

Fields of papers citing papers by Alain De Pover

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alain De Pover. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alain De Pover. The network helps show where Alain De Pover may publish in the future.

Co-authorship network of co-authors of Alain De Pover

This figure shows the co-authorship network connecting the top 25 collaborators of Alain De Pover. A scholar is included among the top collaborators of Alain De Pover based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Alain De Pover. Alain De Pover is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Vaupel, Andrea, Guido Bold, Alain De Pover, et al.. (2014). Tetra-substituted imidazoles as a new class of inhibitors of the p53–MDM2 interaction. Bioorganic & Medicinal Chemistry Letters. 24(9). 2110–2114. 30 indexed citations
3.
Furet, Pascal, Patrick Chêne, Alain De Pover, et al.. (2012). The central valine concept provides an entry in a new class of non peptide inhibitors of the p53–MDM2 interaction. Bioorganic & Medicinal Chemistry Letters. 22(10). 3498–3502. 52 indexed citations
4.
Fritsch, Christine, Christian Schnell, Christian Chatenay‐Rivauday, et al.. (2012). Abstract 3748: NVP-BYL719, a novel PI3Kalpha selective inhibitor with all the characteristics required for clinical development as an anti-cancer agent. Cancer Research. 72(8_Supplement). 3748–3748. 15 indexed citations
5.
Fontana, Patrizia, et al.. (2011). Leveraging the Contribution of Thermodynamics in Drug Discovery with the Help of Fluorescence-Based Thermal Shift Assays. SLAS DISCOVERY. 16(5). 552–556. 6 indexed citations
6.
Weigert, Oliver, Andrew A. Lane, Liat Bird, et al.. (2011). Genetic Resistance to JAK2 Enzymatic Inhibitors Is Overcome by HSP90 Inhibition. Blood. 118(21). 62–62. 4 indexed citations
7.
Gerspacher, Marc, Pascal Furet, Carole Pissot‐Soldermann, et al.. (2010). 2-Amino-aryl-7-aryl-benzoxazoles as potent, selective and orally available JAK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 20(5). 1724–1727. 21 indexed citations
8.
Cowell, David C., et al.. (2010). Hepatobiliary and Pancreatic: Bile duct dilatation caused by an aortic aneurysm. Journal of Gastroenterology and Hepatology. 25(8). 1467–1467. 3 indexed citations
9.
Erdmann, Dirk, et al.. (2010). Simultaneous protein expression and modification: an efficient approach for production of unphosphorylated and biotinylated receptor tyrosine kinases by triple infection in the baculovirus expression system.. PubMed. 21(1). 9–17. 7 indexed citations
10.
Maira, Sauveur-Michel, Frédéric Stauffer, Josef Brueggen, et al.. (2008). Identification and characterization of NVP-BEZ235, a new orally available dual phosphatidylinositol 3-kinase/mammalian target of rapamycin inhibitor with potent in vivo antitumor activity. Molecular Cancer Therapeutics. 7(7). 1851–1863. 954 indexed citations breakdown →
11.
Darimont, Christian, et al.. (2000). Effects of intestinal fatty acid-binding protein overexpression on fatty acid metabolism in Caco-2 cells. Journal of Lipid Research. 41(1). 84–92. 46 indexed citations
12.
Darimont, Christian, et al.. (1999). Epidermal growth factor regulates fatty acid uptake and metabolism in Caco-2 cells. American Journal of Physiology-Gastrointestinal and Liver Physiology. 276(3). G606–G612. 19 indexed citations
13.
Pover, Alain De, et al.. (1999). Properties of the human long and short isoforms of the uncoupling protein‐3 expressed in yeast cells. FEBS Letters. 462(3). 411–415. 43 indexed citations
14.
Darimont, Christian, et al.. (1998). Differential Regulation of Intestinal and Liver Fatty Acid-Binding Proteins in Human Intestinal Cell line (Caco-2): Role of Collagen. Experimental Cell Research. 244(2). 441–447. 21 indexed citations
15.
Thomson, A. B. R., Alain De Pover, M. Keelan, Elżbieta Jarocka‐Cyrta, & M. T. Clandinin. (1997). [1] Inhibition of lipid absorption as an approach to the treatment of obesity. Methods in enzymology on CD-ROM/Methods in enzymology. 286. 3–44. 67 indexed citations
16.
Grupp, I L, G Grupp, David Melvin, et al.. (1993). Characterisation of Na/K-ATPase, its isoforms, and the inotropic response to ouabain in isolated failing human hearts. Cardiovascular Research. 27(12). 2229–2237. 102 indexed citations
17.
Godfraind, Théophile, et al.. (1982). Dihydroouabain is an antagonist of ouabain inotropic action. Nature. 299(5886). 824–826. 18 indexed citations
18.
Pover, Alain De, Gilberto Castañeda‐Hernández, & Théophile Godfraind. (1982). Water versus acetone-HCl extraction of digitalis-like factor from guinea-pig heart. Biochemical Pharmacology. 31(2). 267–271. 30 indexed citations
19.
Godfraind, Théophile, et al.. (1980). Identification with potassium and vanadate of two classes of specific ouabain binding sites in a (Na+ + K+)ATpase preparation from the guinea-pig heart. Biochemical Pharmacology. 29(8). 1195–1199. 21 indexed citations
20.
Godfraind, Théophile, Alain De Pover, & Norbert Verbeke. (1977). Influence of pH and sodium on the inhibition of guinie-pig heart (Na+ + K+)-ATPase by calcium. Biochimica et Biophysica Acta (BBA) - Enzymology. 481(1). 202–211. 29 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026